Rosenberg SA: A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 1999, 10: 281-287. 10.1016/S1074-7613(00)80028-X.
Article
CAS
PubMed
Google Scholar
Eynde Van den BJ, Bruggen van der P: T cell defined tumor antigens. Curr Opin Immunol. 1997, 9: 684-693. 10.1016/S0952-7915(97)80050-7.
Article
PubMed
Google Scholar
Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N, Parmiani G: T-cell recognition of melanoma-associated antigens. J Cell Physiol. 2000, 182: 323-331. 10.1002/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#.
Article
CAS
PubMed
Google Scholar
Zendman AJ, de Wit NJ, van Kraats AA, Weidle UH, Ruiter DJ, van Muijen GN: Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma. Melanoma Res. 2001, 11: 451-459. 10.1097/00008390-200110000-00003.
Article
CAS
PubMed
Google Scholar
Hogan KT, Coppola MA, Gatlin CL, Thompson LW, Shabanowitz J, Hunt DF, Engelhard VH, Ross MM, Slingluff CL: Identification of novel and widely expressed cancer/testis gene isoforms that elicit spontaneous cytotoxic T lymphocyte reactivity to melanoma. Cancer Res. 2004, 64: 1157-1163. 10.1158/0008-5472.CAN-03-2209.
Article
CAS
PubMed
Google Scholar
de Vries TJ, Smeets M, de Graaf R, Hou-Jensen K, Brocker EB, Renard N, Eggermont AM, van Muijen GN, Ruiter DJ: Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. J Pathol. 2001, 193: 13-20. 10.1002/1096-9896(2000)9999:9999<::AID-PATH729>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Cormier JN, Hijazi YM, Abati A, Fetsch P, Bettinotti M, Steinberg SM, Rosenberg SA, Marincola FM: Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer. 1998, 75: 517-524. 10.1002/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.0.CO;2-W.
Article
CAS
PubMed
Google Scholar
Cormier JN, Abati A, Fetsch P, Hijazi YM, Rosenberg SA, Marincola FM, Topalian SL: Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. J Immunother. 1998, 21: 27-31. 10.1097/00002371-199801000-00003.
Article
CAS
PubMed
Google Scholar
Riker A, Cormier J, Panelli M, Kammula U, Wang E, Abati A, Fetsch P, Lee KH, Steinberg S, Rosenberg S, Marincola F: Immune selection after antigen-specific immunotherapy of melanoma. Surgery. 1999, 126: 112-120.
Article
CAS
PubMed
Google Scholar
de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GN, de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GN: Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res. 1997, 57: 3223-3229.
CAS
PubMed
Google Scholar
Slingluff CL, Colella TA, Thompson L, Graham DD, Skipper JC, Caldwell J, Brinckerhoff L, Kittlesen DJ, Deacon DH, Oei C, Harthun NL, Huczko EL, Hunt DF, Darrow TL, Engelhard VH: Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunol Immunother. 2000, 48: 661-672. 10.1007/s002620050015.
Article
CAS
PubMed
Google Scholar
Hogan KT, Eisinger DP, Cupp SB, Lekstrom KJ, Deacon DD, Shabanowitz J, Hunt DF, Engelhard VH, Slingluff CL, Ross MM: The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. Cancer Res. 1998, 58: 5144-5150.
CAS
PubMed
Google Scholar
Segal NH, Parsons DW, Peggs KS, Velculescu V, Kinzler KW, Vogelstein B, Allison JP: Epitope landscape in breast and colorectal cancer. Cancer Res. 2008, 68: 889-892. 10.1158/0008-5472.CAN-07-3095.
Article
CAS
PubMed
Google Scholar
Parmiani G, De Filippo A, Novellino L, Castelli C: Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials. J Immunol. 2007, 178: 1975-1979.
Article
CAS
PubMed
Google Scholar
Berd D, Maguire HC, Mastrangelo MJ: Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res. 1986, 46: 2572-2577.
CAS
PubMed
Google Scholar
Berd D, Maguire HC, McCue P, Mastrangelo MJ: Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients. J Clin Oncol. 1990, 8: 1858-1867.
CAS
PubMed
Google Scholar
Nair SK, Morse M, Boczkowski D, Cumming RI, Vasovic L, Gilboa E, Lyerly HK: Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg. 2002, 235: 540-549. 10.1097/00000658-200204000-00013.
Article
PubMed
PubMed Central
Google Scholar
Heiser A, Maurice MA, Yancey DR, Wu NZ, Dahm P, Pruitt SK, Boczkowski D, Nair SK, Ballo MS, Gilboa E, Vieweg J: Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol. 2001, 166: 2953-2960.
Article
CAS
PubMed
Google Scholar
Testori A, Richards J, Whitman E, Mann GB, Lutzky J, Camacho L, Parmiani G, Tosti G, Kirkwood JM, Hoos A, Yuh L, Gupta R, Srivastava PK, Group CS: Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. J Clin Oncol. 2008, 26: 955-962. 10.1200/JCO.2007.11.9941.
Article
CAS
PubMed
Google Scholar
Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchiano A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P, Parmiani G: Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings[see comment][erratum appears in J Clin Oncol 2002 Dec 1;20(23):4610]. J Clin Oncol. 2002, 20: 4169-4180. 10.1200/JCO.2002.09.134.
Article
CAS
PubMed
Google Scholar
O'Rourke MGE, Johnson M, Lanagan C, See J, Yang J, Bell JR, Slater GJ, Kerr BM, Crowe B, Purdie DM, Elliott SL, Ellem KAO, Schmidt CW: Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunol Immunother. 2003, 52: 387-395.
PubMed
Google Scholar
Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med. 1998, 4: 328-332. 10.1038/nm0398-328.
Article
CAS
PubMed
Google Scholar
Thumann P, Moc I, Humrich J, Berger TG, Schultz ES, Schuler G, Jenne L: Antigen loading of dendritic cells with whole tumor cell preparations. J Immunol Methods. 2003, 277: 1-16. 10.1016/S0022-1759(03)00102-9.
Article
CAS
PubMed
Google Scholar
Berd D, Kairys J, Dunton C, Mastrangelo MJ, Sato T, Maguire HC: Autologous, hapten-modified vaccine as a treatment for human cancers. Semin Oncol. 1998, 25: 646-653.
CAS
PubMed
Google Scholar
Lotem M, Peretz T, Drize O, Gimmon Z, Ad El D, Weitzen R, Goldberg H, Ben David I, Prus D, Hamburger T, Shiloni E: Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer. 2002, 86: 1534-1539. 10.1038/sj.bjc.6600251.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kusumoto M, Umeda S, Ikubo A, Aoki Y, Tawfik O, Oben R, Williamson S, Jewell W, Suzuki T: Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene. Cancer Immunol Immunother. 2001, 50: 373-381. 10.1007/s002620100213.
Article
CAS
PubMed
Google Scholar
Harris JE, Ryan L, Hoover HC, Stuart RK, Oken MM, Benson AB, Mansour E, Haller DG, Manola J, Hanna MG: Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol. 2000, 18: 148-157.
CAS
PubMed
Google Scholar
Abdel-Wahab Z, Weltz C, Hester D, Pickett N, Vervaert C, Barber JR, Jolly D, Seigler HF: A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response[erratum appears in Cancer 1999 Oct 1;86(7):1380]. Cancer. 1997, 80: 401-412. 10.1002/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO;2-U.
Article
CAS
PubMed
Google Scholar
Berd D, Sato T, Mastrangelo MJ: Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses. Cancer Immunol Immunother. 2002, 51: 320-326. 10.1007/s00262-002-0285-3.
Article
CAS
PubMed
Google Scholar
Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR: Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. Journal of Thoracic & Cardiovascular Surgery. 2004, 127: 1078-1086. 10.1016/S0022-5223(03)01321-7.
Article
CAS
Google Scholar
Harlow E, Lane D: Antibodies: A Laboratory Manual. 1988, Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 450-1
Google Scholar
Scanlon EF, Hawkins RA, Fox WW, Smith WS: Fatal homotransplanted melanoma: a case report. Cancer. 1965, 18: 782-789. 10.1002/1097-0142(196506)18:6<782::AID-CNCR2820180616>3.0.CO;2-#.
Article
CAS
PubMed
Google Scholar
Southam CM: Homotransplantation of human cell lines. Bull N Y Acad Med. 1958, 34: 416-423.
CAS
PubMed
Google Scholar
Southam CM, Moore AE: Induced immunity to cancer cell homografts in man. Ann N Y Acad Sci. 1958, 73: 635-653. 10.1111/j.1749-6632.1959.tb40840.x.
Article
CAS
PubMed
Google Scholar
Penn I: Malignant melanoma in organ allograft recipients. Transplantation. 1996, 61: 274-278. 10.1097/00007890-199601270-00019.
Article
CAS
PubMed
Google Scholar
Amendola BE, Wolf AL, Coy SR, Amendola M, Bloch L: Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast. Cancer J. 2000, 6 (2): 88-92.
CAS
PubMed
Google Scholar
Sansur CA, Chin LS, Ames JW, Banegura AT, Aggarwal S, Ballesteros M, Amin P, Simard JM, Eisenberg H: Gamma knife radiosurgery for the treatment of brain metastases. Stereotactic & Functional Neurosurgery. 2000, 74: 37-51. 10.1159/000056462.
Article
CAS
Google Scholar
Seymour CB, Mothersill C, Alper T: High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol Relat Stud Phys Chem Med. 1986, 50 (1): 167-179. 10.1080/09553008614550541.
Article
CAS
PubMed
Google Scholar
Morton CL, Houghton PJ: Establishment of human tumor xenografts in immunodeficient mice. Nature Protocols. 2007, 2: 247-250. 10.1038/nprot.2007.25.
Article
CAS
PubMed
Google Scholar
Verheij M, Bartelink H: Radiation-induced apoptosis. Cell & Tissue Research. 2000, 301: 133-142. 10.1007/s004410000188.
Article
CAS
Google Scholar
Kulms D, Schwarz T: Molecular mechanisms of UV-induced apoptosis. Photodermatology, Photoimmunology & Photomedicine. 2000, 16: 195-201. 10.1034/j.1600-0781.2000.160501.x.
Article
CAS
Google Scholar
Kulms D, Schwarz T: Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol. 2002, 64: 837-841. 10.1016/S0006-2952(02)01146-2.
Article
CAS
PubMed
Google Scholar
Illidge TM: Radiation-induced apoptosis. Clin Oncol (R Coll Radiol). 1998, 10: 3-13.
Article
CAS
Google Scholar
Jonathan EC, Bernhard EJ, McKenna WG: How does radiation kill cells?. Curr Opin Chem Biol. 1999, 3: 77-83. 10.1016/S1367-5931(99)80014-3.
Article
CAS
PubMed
Google Scholar
Hatfield P, Merrick A, Harrington K, Vile R, Bateman A, Selby P, Melcher A: Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?. Clin Oncol (R Coll Radiol). 2005, 17: 1-11.
Article
CAS
Google Scholar
Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA: Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev. 2005, 207: 145-157. 10.1111/j.0105-2896.2005.00316.x.
Article
CAS
PubMed
Google Scholar
Rock KL, Shen L: Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005, 207: 166-183. 10.1111/j.0105-2896.2005.00301.x.
Article
CAS
PubMed
Google Scholar
Willers J, Lucchese A, Mittelman A, Dummer R, Kanduc D: Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp Dermatol. 2005, 14: 543-550. 10.1111/j.0906-6705.2005.00327.x.
Article
CAS
PubMed
Google Scholar